FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Charles Young

Research Profile

Disorders

Chemicals & Drugs

Anatomy

Phenomena

Blotting, Western

Physiology

Concepts & Ideas

Molecular Sequence Data

Co-author Network

Publications

TOP 3
Jing Xiao; Charles Y F Young; Dongqing Chen; Caishu Deng; Alex N Eischeid; Ai-Yu Gong; Xian-Ming Chen
miR-141 modulates androgen receptor transcriptional activity in human prostate cancer cells through targeting the small heterodimer partner protein.
Zhongyi Hu; Zunling Li; Keli Tian; Charles Y F Young; Yuanyuan Gu; Bo Han; Jinsan Zhang; Huiqing Yuan
Knockdown of AGR2 induces cellular senescence in prostate cancer cells.
Saswati Mahapatra; Zhifu Sun; Donald J Tindall; Charles Y F Young; Rafael E Jimenez; Eric W Klee; George G Klee; Krishna Vanaja Donkena
Global methylation profiling for risk prediction of prostate cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Charles Young (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Jing Xiao; Charles Y F Young; Dongqing Chen; Caishu Deng; Alex N Eischeid; Ai-Yu Gong; Xian-Ming Chen
miR-141 modulates androgen receptor transcriptional activity in human prostate cancer cells through targeting the small heterodimer partner protein.
The Prostate 2012;72(14):1514-22.
2012: Zhongyi Hu; Zunling Li; Keli Tian; Charles Y F Young; Yuanyuan Gu; Bo Han; Jinsan Zhang; Huiqing Yuan
Knockdown of AGR2 induces cellular senescence in prostate cancer cells.
Carcinogenesis 2012;33(6):1178-86.
2012: Saswati Mahapatra; Zhifu Sun; Donald J Tindall; Charles Y F Young; Rafael E Jimenez; Eric W Klee; George G Klee; Krishna Vanaja Donkena
Global methylation profiling for risk prediction of prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2012;18(10):2882-95.
2012: Yong-Qing Liu; Yan-Na Cheng; Xiao-Yan Hu; Tao Lu; Charles Y F Young; Hui-Qing Yuan; Hong-Xiang Lou
Retigeric acid B exhibits antitumor activity through suppression of nuclear factor-κB signaling in prostate cancer cells in vitro and in vivo.
PloS one 2012;7(5):e38000.
2012: Saswati Mahapatra; Donald J Tindall; Charles Y F Young; Michael W Holmes; R Jeffrey Karnes; Eric W Klee; Manish Kohli; Krishna Vanaja Donkena
Antiangiogenic Effects and Therapeutic Targets of Azadirachta indica Leaf Extract in Endothelial Cells.
Evidence-based complementary and alternative medicine : eCAM 2012;2012():303019.
2011: Saswati Mahapatra; Donald J Tindall; Charles Y F Young; John C Cheville; Michael W Holmes; R Jeffrey Karnes; Eric W Klee; Manish Kohli; Krishna Vanaja Donkena
Novel molecular targets of Azadirachta indica associated with inhibition of tumor growth in prostate cancer.
The AAPS journal 2011;13(3):365-77.
2011: Guangmin Xi; Xiaoyan Hu; Baolin Wu; Hanming Jiang; Charles Y F Young; Yingxin Pang; Huiqing Yuan
Autophagy inhibition promotes paclitaxel-induced apoptosis in cancer cells.
Cancer letters 2011;307(2):141-8.
2011: Yan Ding; Xiaoling Wang; Aihui Xu; Xia Xu; Keli Tian; Charles Y F Young; Huiqing Yuan
Associations of saposin C, Src, and androgen receptor upregulate the expression and function of androgen receptor in human prostate cancer cells.
Journal of cellular biochemistry 2011;112(3):818-28.
2011: Krishna Vanaja Donkena; Charles Y F Young
Vitamin d, sunlight and prostate cancer risk.
Advances in preventive medicine 2011;2011():281863.
2010: Han Liu; Yi-qing Liu; Yong-qing Liu; Ai-hui Xu; Charles Y F Young; Hui-Qing Yuan; Hong-Xiang Lou
A novel anticancer agent, retigeric acid B, displays proliferation inhibition, S phase arrest and apoptosis activation in human prostate cancer cells.
Chemico-biological interactions 2010;188(3):598-606.
2010: Krishna V. Donkena; H Yuan; Charles Y F Young
Vitamin Bs, one carbon metabolism and prostate cancer.
Mini reviews in medicinal chemistry 2010;10(14):1385-92.
2010: Yingxin Pang; Charles Y F Young; Huiqing Yuan
MicroRNAs and prostate cancer.
Acta biochimica et biophysica Sinica 2010;42(6):363-9.
2010: K V Donkena; H Yuan; Charles Y F Young
Recent advances in understanding hormonal therapy resistant prostate cancer.
Current cancer drug targets 2010;10(4):402-10.
2010: Huiqing Yuan; Charles Y F Young; Yuanyuan Tian; Zhifang Liu; Mengye Zhang; Hongxiang Lou
Suppression of the androgen receptor function by quercetin through protein-protein interactions of Sp1, c-Jun, and the androgen receptor in human prostate cancer cells.
Molecular and cellular biochemistry 2010;339(1-2):253-62.
2010: Krishna Vanaja Donkena; R Jeffrey Karnes; Charles Y F Young
Vitamins and prostate cancer risk.
Molecules (Basel, Switzerland) 2010;15(3):1762-83.
2010: Krishna Vanaja Donkena; Charles Y F Young; Donald J Tindall
Oxidative stress and DNA methylation in prostate cancer.
Obstetrics and gynecology international 2010;2010():302051.
2009: Meilan He; Donkena Krishna Vanaja; R Jeffrey Karnes; Charles Y F Young
Epigenetic regulation of Myc on retinoic acid receptor beta and PDLIM4 in RWPE1 cells.
The Prostate 2009;69(15):1643-50.
2009: Aiyu Gong; Meilan He; Donkena Krishna Vanaja; Ping Yin; R Jeffrey Karnes; Charles Y F Young
Phenethyl isothiocyanate inhibits STAT3 activation in prostate cancer cells.
Molecular nutrition & food research 2009;53(7):878-86.
2009: Donkena Krishna Vanaja; Mathias Ehrich; Dirk van den Boom; John C Cheville; R Jeffrey Karnes; Donald J Tindall; Charles R Cantor; Charles Y F Young
Hypermethylation of genes for diagnosis and risk stratification of prostate cancer.
Cancer investigation 2009;27(5):549-60.
2009: Meilan He; Charles Y F Young
New approaches to target the androgen receptor and STAT3 for prostate cancer treatments.
Mini reviews in medicinal chemistry 2009;9(3):395-400.
2009: Donkena Krishna Vanaja; Michael E Grossmann; John C Cheville; Mozammel H Gazi; Aiyu Gong; Jin San Zhang; Katalin Ajtai; Thomas P Burghardt; Charles Y F Young
PDLIM4, an actin binding protein, suppresses prostate cancer cell growth.
Cancer investigation 2009;27(3):264-72.
2008: Hui-Qing Yuan; Feng Kong; Xiao-Ling Wang; Charles Y F Young; Xiao-Yan Hu; Hong-Xiang Lou
Inhibitory effect of acetyl-11-keto-beta-boswellic acid on androgen receptor by interference of Sp1 binding activity in prostate cancer cells.
Biochemical pharmacology 2008;75(11):2112-21.
2008: Charles Y F Young; H-Q Yuan; M-L He; J-Y Zhang
Carotenoids and prostate cancer risk.
Mini reviews in medicinal chemistry 2008;8(5):529-37.
2008: Mozammel H Gazi; MeiLan He; John C Cheville; Charles Y F Young
Downregulation of IgG Fc binding protein (Fc gammaBP) in prostate cancer.
Cancer biology & therapy 2008;7(1):70-5.
2007: Charles Y F Young
Recent approaches in chemoprevention of prostate cancer.
Current cancer drug targets 2007;7(7):681-8.
2007: Yan Ding; Hui-Qing Yuan; Feng Kong; Xiao-Yan Hu; Kai Ren; Jie Cai; Xiao-Ling Wang; Charles Y F Young
Ectopic expression of neurotrophic peptide derived from saposin C increases proliferation and upregulates androgen receptor expression and transcriptional activity in human prostate cancer cells.
Asian journal of andrology 2007;9(5):601-9.
2007: Mozammel H Gazi; Ai-Yu Gong; Krishna V. Donkena; Charles Y F Young
Sodium selenite inhibits interleukin-6-mediated androgen receptor activation in prostate cancer cells via upregulation of c-Jun.
Clinica chimica acta; international journal of clinical chemistry 2007;380(1-2):145-50.
2007: Hui-Na Zhang; Chun-Xiao Yu; Peng-Ju Zhang; Wei-Wen Chen; An-Li Jiang; Feng Kong; Jing Ti Deng; Jian-Ye Zhang; Charles Y F Young
Curcumin downregulates homeobox gene NKX3.1 in prostate cancer cell LNCaP.
Acta pharmacologica Sinica 2007;28(3):423-30.
2007: J-S Zhang; Ai-Yu Gong; Charles Y F Young
ZNF185, an actin-cytoskeleton-associated growth inhibitory LIM protein in prostate cancer.
Oncogene 2007;26(1):111-22.
2006: Mei-Lan He; Hui-Qing Yuan; An-Li Jiang; Ai-Yu Gong; Wei-Wen Chen; Peng-Ju Zhang; Charles Y F Young; Jian-Ye Zhang
Gum mastic inhibits the expression and function of the androgen receptor in prostate cancer cells.
Cancer 2006;106(12):2547-55.
2006: Byung Ha Chung; Hye-young Lee; Jae Seok Lee; Charles Y F Young
Perillyl alcohol inhibits the expression and function of the androgen receptor in human prostate cancer cells.
Cancer letters 2006;236(2):222-8.
2006: Donkena Krishna Vanaja; Karla V Ballman; Bruce W Morlan; John C Cheville; Roxann M Neumann; Michael M Lieber; Donald J Tindall; Charles Y F Young
PDLIM4 repression by hypermethylation as a potential biomarker for prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(4):1128-36.
2005: Jin-San Zhang; Ai-Yu Gong; John C Cheville; David I Smith; Charles Y F Young
AGR2, an androgen-inducible secretory protein overexpressed in prostate cancer.
Genes, chromosomes & cancer 2005;43(3):249-59.
2005: Huiqing Yuan; Ai-Yu Gong; Charles Y F Young
Involvement of transcription factor Sp1 in quercetin-mediated inhibitory effect on the androgen receptor in human prostate cancer cells.
Carcinogenesis 2005;26(4):793-801.
2005: Pengju Zhang; Jianye Zhang; Charles Y F Young; Pai C Kao; Weiwen Chen; Anli Jiang; Lianying Zhang; Qiang Guo
Decoy androgen-responsive element DNA can inhibit androgen receptor transactivation of the PSA promoter gene.
Annals of clinical and laboratory science 2005;35(3):278-84.
2004: Huiqing Yuan; Yunqian Pan; Charles Y F Young
Overexpression of c-Jun induced by quercetin and resverol inhibits the expression and function of the androgen receptor in human prostate cancer cells.
Cancer letters 2004;213(2):155-63.
2004: Michael E Grossmann; Benjamin J Madden; Fan Gao; Yuan-Ping Pang; John E Carpenter; Daniel McCormick; Charles Y F Young
Proteomics shows Hsp70 does not bind peptide sequences indiscriminately in vivo.
Experimental cell research 2004;297(1):108-17.
2004: Sung Dae Cho; Cheng Jiang; Barbara Malewicz; Yan Dong; Charles Y F Young; Kyung-Sun Kang; Yong-Soon Lee; Clement Ip; Junxuan Lü
Methyl selenium metabolites decrease prostate-specific antigen expression by inducing protein degradation and suppressing androgen-stimulated transcription.
Molecular cancer therapeutics 2004;3(5):605-11.
2004: Charles Y F Young; Aminah Jatoi; John Ward; Michael L Blute
The effects of dietary factors on the androgen receptor and related cellular factors in prostate cancer.
Current medicinal chemistry 2004;11(7):909-23.
2004: Ming-Hsien Wang; M E Grossmann; Charles Y F Young
Forced expression of heat-shock protein 70 increases the secretion of Hsp70 and provides protection against tumour growth.
British journal of cancer 2004;90(4):926-31.
2003: Yunqian Pan; Jin-San Zhang; Mozammel H Gazi; Charles Y F Young
The cyclooxygenase 2-specific nonsteroidal anti-inflammatory drugs celecoxib and nimesulide inhibit androgen receptor activity via induction of c-Jun in prostate cancer cells.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2003;12(8):769-74.
2003: Christine Spitzweg; IV Scholz; Elizabeth R Bergert; DJ Tindall; Charles Y F Young; Burkhard Göke; John C Morris
Retinoic acid-induced stimulation of sodium iodide symporter expression and cytotoxicity of radioiodine in prostate cancer cells.
Endocrinology 2003;144(8):3423-32.
2003: Donkena Krishna Vanaja; John C Cheville; Steve J Iturria; Charles Y F Young
Transcriptional silencing of zinc finger protein 185 identified by expression profiling is associated with prostate cancer progression.
Cancer research 2003;63(14):3877-82.
2003: Ming-Hsien Wang; Yamilka Abreu-Delgado; Charles Y F Young
Effects of vitamin C on androgen receptor mediated actions in human prostate adenocarcinoma cell line LAPC-4.
Urology 2003;62(1):167-71.
2003: Weiwen Chen; Jianye Zhang; Charles Y F Young; Lianying Zhang; Liucun Chen; Jian Zhao
The RFA regulatory sequence-binding protein in the promoter of prostate-specific antigen gene.
Science in China. Series C, Life sciences / Chinese Academy of Sciences 2003;46(2):184-93.
2003: Aminah Jatoi; Neil Ellison; Patrick A Burch; Jeff A Sloan; Shaker R Dakhil; Paul J Novotny; Winston Tan; Tom R Fitch; Kendrith M Rowland; Charles Y F Young; Patrick J Flynn
A phase II trial of green tea in the treatment of patients with androgen independent metastatic prostate carcinoma.
Cancer 2003;97(6):1442-6.
2003: Jie Liu; Jin-San Zhang; Charles Y F Young; Pai C Kao
Polymorphisms of prostate-specific antigen gene promoter: determination from cord blood collected on filter paper.
Annals of clinical and laboratory science 2003;33(4):429-34.
2002: Fan J Meng; Ailin Shan; Long Jin; Charles Y F Young
The expression of a variant prostate-specific antigen in human prostate.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2002;11(3):305-9.
2002: Donkena Krishna Vanaja; Susan H Mitchell; David O Toft; Charles Y F Young
Effect of geldanamycin on androgen receptor function and stability.
Cell stress & chaperones 2002;7(1):55-64.
2001: Christine Spitzweg; A B Dietz; Michael K O'Connor; Elizabeth R Bergert; DJ Tindall; Charles Y F Young; John C Morris
In vivo sodium iodide symporter gene therapy of prostate cancer.
Gene therapy 2001;8(20):1524-31.
2001: Wenmiao Zhu; J S Zhang; Charles Y F Young
Silymarin inhibits function of the androgen receptor by reducing nuclear localization of the receptor in the human prostate cancer cell line LNCaP.
Carcinogenesis 2001;22(9):1399-403.
2001: B H Chung; Susan H Mitchell; J S Zhang; Charles Y F Young
Effects of docosahexaenoic acid and eicosapentaenoic acid on androgen-mediated cell growth and gene expression in LNCaP prostate cancer cells.
Carcinogenesis 2001;22(8):1201-6.
2001: N Xing; J Qian; D Bostwick; E Bergstralh; Charles Y F Young
Neuroendocrine cells in human prostate over-express the anti-apoptosis protein survivin.
The Prostate 2001;48(1):7-15.
2001: N Xing; Y Chen; Susan H Mitchell; Charles Y F Young
Quercetin inhibits the expression and function of the androgen receptor in LNCaP prostate cancer cells.
Carcinogenesis 2001;22(3):409-14.
2001: W Zhu; Charles Y F Young
Androgen-Dependent transcriptional regulation of the prostate-specific antigen gene by thyroid hormone 3,5,3'-L-triiodothyronine.
Journal of andrology 2001;22(1):136-41.
2000: Christine Spitzweg; Michael K O'Connor; Elizabeth R Bergert; DJ Tindall; Charles Y F Young; John C Morris
Treatment of prostate cancer by radioiodine therapy after tissue-specific expression of the sodium iodide symporter.
Cancer research 2000;60(22):6526-30.
2000: Susan H Mitchell; PE Murtha; S Zhang; Wenmiao Zhu; Charles Y F Young
An androgen response element mediates LNCaP cell dependent androgen induction of the hK2 gene.
Molecular and cellular endocrinology 2000;168(1-2):89-99.
2000: Donkena Krishna Vanaja; M E Grossmann; E Celis; Charles Y F Young
Tumor prevention and antitumor immunity with heat shock protein 70 induced by 15-deoxy-delta12,14-prostaglandin J2 in transgenic adenocarcinoma of mouse prostate cells.
Cancer research 2000;60(17):4714-8.
2000: F Ren; S Zhang; Susan H Mitchell; R Butler; Charles Y F Young
Tea polyphenols down-regulate the expression of the androgen receptor in LNCaP prostate cancer cells.
Oncogene 2000;19(15):1924-32.
2000: R Butler; Susan H Mitchell; D J Tindall; Charles Y F Young
Nonapoptotic cell death associated with S-phase arrest of prostate cancer cells via the peroxisome proliferator-activated receptor gamma ligand, 15-deoxy-delta12,14-prostaglandin J2.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 2000;11(1):49-61.
1999: Susan H Mitchell; Wenmiao Zhu; Charles Y F Young
Resveratrol inhibits the expression and function of the androgen receptor in LNCaP prostate cancer cells.
Cancer research 1999;59(23):5892-5.
1999: Alan W Partin; William J Catalona; Judith A Finlay; Claude Darte; Donald J Tindall; Charles Y F Young; George G Klee; Daniel W Chan; Harry G Rittenhouse; RL Wolfert; David L Woodrum
Use of human glandular kallikrein 2 for the detection of prostate cancer: preliminary analysis.
Urology 1999;54(5):839-45.
1999: Wenmiao Zhu; A Smith; Charles Y F Young
A nonsteroidal anti-inflammatory drug, flufenamic acid, inhibits the expression of the androgen receptor in LNCaP cells.
Endocrinology 1999;140(11):5451-4.
1999: George G Klee; Marcia K Goodmanson; S J Jacobsen; Charles Y F Young; Judith A Finlay; Harry G Rittenhouse; RL Wolfert; Donald J Tindall
Highly sensitive automated chemiluminometric assay for measuring free human glandular kallikrein-2.
Clinical chemistry 1999;45(6 Pt 1):800-6.
1999: Christine Spitzweg; S Zhang; Elizabeth R Bergert; M Regina Castro; Bryan McIver; Armin E Heufelder; DJ Tindall; Charles Y F Young; John C Morris
Prostate-specific antigen (PSA) promoter-driven androgen-inducible expression of sodium iodide symporter in prostate cancer cell lines.
Cancer research 1999;59(9):2136-41.
1999: MF Darson; Anna Pacelli; P Roche; Harry G Rittenhouse; RL Wolfert; M S Saeid; Charles Y F Young; George G Klee; Donald J Tindall; David G Bostwick
Human glandular kallikrein 2 expression in prostate adenocarcinoma and lymph node metastases.
Urology 1999;53(5):939-44.
1999: S Zhang; M L Hsieh; Wenmiao Zhu; George G Klee; Donald J Tindall; Charles Y F Young
Interactive effects of triiodothyronine and androgens on prostate cell growth and gene expression.
Endocrinology 1999;140(4):1665-71.
1999: MC Charlesworth; Charles Y F Young; V M Miller; Donald J Tindall
Kininogenase activity of prostate-derived human glandular kallikrein (hK2) purified from seminal fluid.
Journal of andrology 1999;20(2):220-9.
1998: A G Paschka; R Butler; Charles Y F Young
Induction of apoptosis in prostate cancer cell lines by the green tea component, (-)-epigallocatechin-3-gallate.
Cancer letters 1998;130(1-2):1-7.
1997: PE Murtha; Wenmiao Zhu; J Zhang; S Zhang; Charles Y F Young
Effects of Ca++ mobilization on expression of androgen-regulated genes: interference with androgen receptor-mediated transactivation by AP-I proteins.
The Prostate 1997;33(4):264-70.
1997: J Zhang; S Zhang; PE Murtha; Wenmiao Zhu; S S Hou; Charles Y F Young
Identification of two novel cis-elements in the promoter of the prostate-specific antigen gene that are required to enhance androgen receptor-mediated transactivation.
Nucleic acids research 1997;25(15):3143-50.
1997: M L Hsieh; MC Charlesworth; Marcia K Goodmanson; S Zhang; T Seay; George G Klee; Donald J Tindall; Charles Y F Young
Expression of human prostate-specific glandular kallikrein protein (hK2) in the breast cancer cell line T47-D.
Cancer research 1997;57(13):2651-6.
1997: MF Darson; Anna Pacelli; P Roche; Harry G Rittenhouse; RL Wolfert; Charles Y F Young; George G Klee; Donald J Tindall; David G Bostwick
Human glandular kallikrein 2 (hK2) expression in prostatic intraepithelial neoplasia and adenocarcinoma: a novel prostate cancer marker.
Urology 1997;49(6):857-62.
1997: MC Charlesworth; Charles Y F Young; George G Klee; MS Saedi; Stephen D Mikolajczyk; Judith A Finlay; Donald J Tindall
Detection of a prostate-specific protein, human glandular kallikrein (hK2), in sera of patients with elevated prostate-specific antigen levels.
Urology 1997;49(3):487-93.
1997: S Zhang; PE Murtha; Charles Y F Young
Defining a functional androgen responsive element in the 5' far upstream flanking region of the prostate-specific antigen gene.
Biochemical and biophysical research communications 1997;231(3):784-8.
1996: LS Grauer; MC Charlesworth; MS Saedi; Judith A Finlay; R S Liu; Kristine Kuus-Reichel; Charles Y F Young; Donald J Tindall
Identification of human glandular kallikrein hK2 from LNCaP cells.
Journal of andrology 1996;17(4):353-9.
1996: Charles Y F Young; T Seay; K Hogen; MC Charlesworth; P C Roche; George G Klee; Donald J Tindall
Prostate-specific human kallikrein (hK2) as a novel marker for prostate cancer.
The Prostate. Supplement 1996;7():17-24.
1995: W Zhu; PE Murtha; Charles Y F Young
Calpain inhibitor-induced apoptosis in human prostate adenocarcinoma cells.
Biochemical and biophysical research communications 1995;214(3):1130-7.
1995: MS Saedi; M M Cass; AS Goel; LS Grauer; K L Hogen; T Okaneya; B Y Griffin; George G Klee; Charles Y F Young; Donald J Tindall
Overexpression of a human prostate-specific glandular kallikrein, hK2, in E. coli and generation of antibodies.
Molecular and cellular endocrinology 1995;109(2):237-41.
1995: Charles Y F Young; P E Andrews; Donald J Tindall
Expression and androgenic regulation of human prostate-specific kallikreins.
Journal of andrology 1995;16(2):97-9.
1995: D L Schaffner; Roberto Barrios; M R Shaker; S Rajagopalan; S L Huang; D J Tindall; Charles Y F Young; Paul A Overbeek; RM Lebovitz; Michael W Lieberman
Transgenic mice carrying a PSArasT24 hybrid gene develop salivary gland and gastrointestinal tract neoplasms.
Laboratory investigation; a journal of technical methods and pathology 1995;72(3):283-90.
1994: Charles Y F Young; PE Murtha; P E Andrews; J K Lindzey; Donald J Tindall
Antagonism of androgen action in prostate tumor cells by retinoic acid.
The Prostate 1994;25(1):39-45.
1994: Charles Y F Young; PE Murtha; J Zhang
Tumor-promoting phorbol ester-induced cell death and gene expression in a human prostate adenocarcinoma cell line.
Oncology research 1994;6(4-5):203-10.
1993: PE Murtha; Donald J Tindall; Charles Y F Young
Androgen induction of a human prostate-specific kallikrein, hKLK2: characterization of an androgen response element in the 5' promoter region of the gene.
Biochemistry 1993;32(25):6459-64.
1992: P E Andrews; Charles Y F Young; B T Montgomery; Donald J Tindall
Tumor-promoting phorbol ester down-regulates the androgen induction of prostate-specific antigen in a human prostatic adenocarcinoma cell line.
Cancer research 1992;52(6):1525-9.
1992: Charles Y F Young; P E Andrews; B T Montgomery; Donald J Tindall
Tissue-specific and hormonal regulation of human prostate-specific glandular kallikrein.
Biochemistry 1992;31(3):818-24.
1992: B T Montgomery; Charles Y F Young; D L Bilhartz; P E Andrews; J L Prescott; N F Thompson; Donald J Tindall
Hormonal regulation of prostate-specific antigen (PSA) glycoprotein in the human prostatic adenocarcinoma cell line, LNCaP.
The Prostate 1992;21(1):63-73.
1991: Charles Y F Young; B T Montgomery; P E Andrews; S D Qui; D L Bilhartz; Donald J Tindall
Hormonal regulation of prostate-specific antigen messenger RNA in human prostatic adenocarcinoma cell line LNCaP.
Cancer research 1991;51(14):3748-52.
1990: Charles Y F Young; S D Qiu; J L Prescott; Donald J Tindall
Overexpression of a partial human androgen receptor in E. coli: characterization of steroid binding, DNA binding, and immunological properties.
Molecular endocrinology (Baltimore, Md.) 1990;4(12):1841-9.
1990: S D Qiu; Charles Y F Young; D L Bilhartz; J L Prescott; George M Farrow; W W He; Donald J Tindall
In situ hybridization of prostate-specific antigen mRNA in human prostate.
The Journal of urology 1990;144(6):1550-6.
1990: W W He; Leslie M Fischer; S Sun; D L Bilhartz; X P Zhu; Charles Y F Young; D B Kelley; D J Tindall
Molecular cloning of androgen receptors from divergent species with a polymerase chain reaction technique: complete cDNA sequence of the mouse androgen receptor and isolation of androgen receptor cDNA probes from dog, guinea pig and clawed frog.
Biochemical and biophysical research communications 1990;171(2):697-704.
1989: Charles Y F Young; M P Johnson; J L Prescott; Donald J Tindall
The androgen receptor of the testicular-feminized (Tfm) mutant mouse is smaller than the wild-type receptor.
Endocrinology 1989;124(2):771-5.
1988: Charles Y F Young; Lata J Murthy; J L Prescott; M P Johnson; David R Rowley; Glenn R Cunningham; C S Killian; Peter T Scardino; A VonEschenbach; Donald J Tindall
Monoclonal antibodies against the androgen receptor: recognition of human and other mammalian androgen receptors.
Endocrinology 1988;123(1):601-10.
1987: M P Johnson; Charles Y F Young; David R Rowley; Donald J Tindall
A common molecular weight of the androgen receptor monomer in different target tissues.
Biochemistry 1987;26(11):3174-82.
1986: David R Rowley; R T Premont; M P Johnson; Charles Y F Young; Donald J Tindall
Properties of an intermediate-sized androgen receptor: association with RNA.
Biochemistry 1986;25(22):6988-95.
1986: Lata J Murthy; M P Johnson; David R Rowley; Charles Y F Young; Peter T Scardino; Donald J Tindall
Characterization of steroid receptors in human prostate using mibolerone.
The Prostate 1986;8(3):241-53.